Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19–Associated Coagulopathy
Paul Masi(Associated Research (United States)), Corinne Frère(Inserm), Guillaume Lebreton(Inserm), Nicolas Bréchot(Inserm), Isabelle Martin‐Toutain(Inserm), Juliette Chommeloux(Sorbonne Université), Ania Nieszkowska(Assistance Publique – Hôpitaux de Paris), Cyrielle Desnos, Alain Combes(Sorbonne Université), Matthieu Schmidt(Inserm), Marc Pineton de Chambrun(Inserm), Manon Lejeune(Inserm), Charles Edouard Luyt(Sorbonne Université), Guillaume Hékimian(Inserm)
Cited by 121
Related Papers
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry
|The Lancet|2020|945
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
|New England Journal of Medicine|2018|894
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
|Intensive Care Medicine|2023|855
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
|Cochrane Database of Systematic Reviews|2017|648
Position Paper for the Organization of Extracorporeal Membrane Oxygenation Programs for Acute Respiratory Failure in Adult Patients
|American Journal of Respiratory and Critical Care Medicine|2014|518